STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,310,260 | +56.8% | 2,687,658 | +56.7% | 0.00% | – |
Q1 2024 | $23,159,979 | +167.1% | 1,715,554 | +4.1% | 0.00% | – |
Q4 2023 | $8,671,120 | +35.0% | 1,648,502 | +1.1% | 0.00% | – |
Q3 2023 | $6,424,912 | -62.4% | 1,630,688 | +1.5% | 0.00% | – |
Q2 2023 | $17,080,114 | +81.1% | 1,606,784 | +41.9% | 0.00% | – |
Q1 2023 | $9,429,452 | -36.2% | 1,131,987 | -29.3% | 0.00% | – |
Q4 2022 | $14,786,876 | -43.8% | 1,602,045 | -21.8% | 0.00% | -100.0% |
Q3 2022 | $26,295,000 | -0.2% | 2,047,904 | +2.7% | 0.00% | 0.0% |
Q2 2022 | $26,354,000 | -35.4% | 1,995,033 | +2.9% | 0.00% | 0.0% |
Q1 2022 | $40,824,000 | -11.0% | 1,939,390 | +1.4% | 0.00% | 0.0% |
Q4 2021 | $45,873,000 | -2.4% | 1,912,182 | +3.5% | 0.00% | 0.0% |
Q3 2021 | $47,003,000 | -19.7% | 1,847,615 | +6.3% | 0.00% | 0.0% |
Q2 2021 | $58,527,000 | -9.3% | 1,738,802 | +4.7% | 0.00% | -50.0% |
Q1 2021 | $64,514,000 | -35.1% | 1,661,011 | +3.4% | 0.00% | -33.3% |
Q4 2020 | $99,475,000 | +127.4% | 1,606,268 | +23.0% | 0.00% | +200.0% |
Q3 2020 | $43,737,000 | +43.6% | 1,305,960 | +2.2% | 0.00% | 0.0% |
Q2 2020 | $30,462,000 | +67.1% | 1,278,341 | +60.6% | 0.00% | 0.0% |
Q1 2020 | $18,229,000 | -16.7% | 795,990 | +3.0% | 0.00% | 0.0% |
Q4 2019 | $21,886,000 | +51.2% | 772,804 | +14.7% | 0.00% | 0.0% |
Q3 2019 | $14,476,000 | +396.3% | 673,584 | +573.6% | 0.00% | – |
Q2 2019 | $2,917,000 | – | 100,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |